Dataset from A Randomized, Double-blind, Placebo-Controlled, Repeat-dose, Single-center Phase 1a Study to Determine the Safety, Tolerability, and Pharmacokinetics of Lanadelumab Administered Intravenously in Healthy Adult Volunteer Subjects
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009406
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study to evaluate the safety, tolerability and pharmacokinetics (PK) of
lanadelumab administered by Intravenous (IV) infusion in healthy adult volunteers.
创建时间：
2024-11-26
